Generics 227

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Levetiracetam manufacturers

227 products found

Filters

227 products found

levetiracetam

Vials, injection 100 mg/ml - 7 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Belgium , France , Germany , Italy , Netherlands , Portugal , United Kingdom , Vietnam
Registered in
Belgium , France , Germany , Italy , Netherlands , Portugal , Spain , United Kingdom
Manufacturer #15084
This European pharmaceutical company specializes in the Central Nervous System (CNS) and Hospital Injectables. They operate in a niche market focusing on treatments for debilitating conditions like chronic pain and addiction. With a strong commitment to patient care, they are actively seeking new opportunities to expand their product portfolio and geographical reach, particularly within the EU market. Their core therapy areas include CNS disorders, pain management, and addiction treatment. The company has a robust research and development (R&D) program and actively seeks strategic partnerships to further its growth. This company develops and produces both prescription and over-the-counter (OTC) medications in various dosage forms, including injectables, solids, and liquids, which are manufactured under EU and other GMP standards. They hold numerous patents for their innovative drug formulations and have a track record of successful acquisitions, demonstrating their commitment to expanding their presence in the pharmaceutical industry. This company has a solid presence in the European market with an expansion into the Asia region, and is actively pursuing opportunities to expand its global footprint.

Manufacturer usually replies in 18 days

levetiracetam

Tablets, film coated 1500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Spain , United Kingdom , Germany , France
Registered in
Hungary , France
Manufacturer #370
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 20+ years. Key production lines are Rx and OTC. Main therapeutic areas include oncology, urology, and antivirals. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 3 days

levetiracetam

Tablets 250 mg, 500 mg, 750 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , Poland , United Kingdom , Vietnam
Registered in
France
MAs for sale
France
Comments
Ref. Keppra;
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

Want to see all 227 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Liraglutide Manufacturers

When other medications failed to control blood sugar levels well enough, liraglutide injection (Victoza) is used with a diet and Children and adults aged 10 and up having type 2 diabetes can use an exercise regimen to help control their blood sugar levels. In individuals with type 2 diabetes mellitus with heart and blood vessel disease, liraglutide injection (Victoza) is also used to lower the risk of a heart attack, stroke, or death. Adults with type 1 diabetes or diabetic ketoacidosis are not treated with liraglutide injection (Victoza). Liraglutide injection (Saxenda) is used in combination with a low-calorie diet and exercise regimen to help children and adults 12 years of age and older who weigh 132 pounds (60 kg) or more and are overweight or obese with weight-related health issues lose weight and keep it off. Type 2 diabetes is not treated with liraglutide injection (Saxenda). Best brand of Liraglutide is Saxenda, Victoza and Xultophy. Liraglutide may have some side effects like the problem of urinating or pain or burning on urination, injection site rash or redness, headache, migraine, constipation, indigestion, runny nose, sniffing, or cough weariness.

How does Liraglutide work?

When blood sugar levels are high, it helps the pancreas release the appropriate quantity of insulin. Insulin aids in the transport of sugar from the bloodstream to various body tissues where it is used for energy. Liraglutide injection also slows stomach emptying, which may reduce hunger and produce weight loss. Liraglutide (Saxenda) is a glucagon-like peptide-1 (GLP-1) receptor agonist that slows stomach emptying and improves satiety after eating in addition to boosting insulin release and blocking glucagon secretion. It is marketed as a supplement to diet and exercise for weight loss in overweight or obese individuals.

The Cost of Liraglutide

An online search for the wholesale price for sale of Liraglutide for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. Liraglutide medicine is currently accessible in over 100 countries under the brand name Victoza, including but not limited to Canada, Japan, Brazil, Malaysia, Singapore, India, the United Arab Emirates, Iran, and others. In Australia, Iran, Israel, and North America, the same active ingredient is sold under the brand name Saxenda. Sexanda, unlike Victoza, is available in higher concentrations: it's also available for the Victoza multidose pen in 2.4mg and 3mg active substance solutions. It's also sold under the brand name Xultophy in some countries as a combination solution with the component insulin degludec, at a concentration of 100IU + 3.6mg. Novo Nordisk A/S, a Danish corporation, developed and distributes liraglutide internationally, and was granted a patent on the medicine that is valid until 2022. The price of Liraglutide 8mg per 1 ml of size 5 costs $272.22.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Liraglutide distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Liraglutide suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Liraglutide. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Liraglutide is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Liraglutide suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Liraglutide Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation